Target intelligence / Profile preview

Mesogenin-1 (MSGN1)

Target
MSGN1
Molecular classification
Transcription factor, Basic helix-loop-helix (bHLH) transcription factor
01

Overview

Mesogenin-1 (MSGN1) is a basic helix-loop-helix (bHLH) transcription factor critically required for the specification and differentiation of the paraxial mesoderm during embryonic development in vertebrates. MSGN1 is expressed specifically and transiently in the presomitic mesoderm, where it acts as a master regulatory switch activating the transcriptional programs necessary for paraxial mesoderm identity, segmentation (somite formation), cell movement, and epithelial-mesenchymal transition (EMT). MSGN1 induces key regulators such as Tbx6 as well as genes controlling EMT, Notch signaling, and planar cell polarity. It is directly downstream of canonical Wnt signaling and Tbx6, integrating developmental signals to drive trunk musculoskeletal fate and suppress alternate (neural) cell fates in bipotent stem cell populations. Gene knockouts in mice result in substantially diminished presomitic mesoderm and absence of somites along the trunk axis, with profound defects in musculoskeletal development. While MSGN1 does not currently represent a therapeutic target or disease biomarker, its essential position in embryonic patterning makes it a focus for basic developmental biology and regenerative medicine research.

Other names
Mesogenin 1MSGN1pMsgn1pMesogenin1Paraxial mesoderm-specific mesogenin1paraxial mesogeninMSOGmesogenin-1
02

Biological functions

Regulation of paraxial presomitic mesoderm (PSM) specification and differentiationControl of segmentation (somite formation)Regulation of epithelial-mesenchymal transition (EMT)Regulation of cell motility and movement during developmentSpecification and maintenance of musculoskeletal progenitor fatesRegulation of transcription by RNA polymerase IIInhibition of neural fate selection in bipotent stem cellsPromotes muscle and cartilage development
03

Disease associations

Other (active research context; not directly implicated in human disease)Congenital disorders of segmentation/mesoderm patterning (based on knockout mouse phenotypes: somite absence, trunk development failure)

Beyond the preview

Go deeper on Mesogenin-1 (MSGN1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mesogenin-1 (MSGN1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call